Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

Author： Nishiguchi Shuhei   Enomoto Hirayuki   Aizawa Nobuhiro   Nishikawa Hiroki   Osaki Yukio   Tsuda Yasuhiro   Higuchi Kazuhide   Okazaki Kazuichi   Seki Toshihito   Kim Soo   Hongo Yasushi   Jyomura Hisato   Nishida Naoshi   Kudo Masatoshi  

Publisher： Springer Publishing Company

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.49, Iss.3, 2014-03, pp. : 492-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype

By  

Case Reports in Gastroenterology, Vol. 9, Iss. 2, 2015-07 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Sustained Virological Response After 4 Weeks of Telaprevir, Peginterferon, and Ribavirin in an Asian Patient with Genotype 1 Chronic Hepatitis C and IL28B Genotype CC

By Brulotte Natalie   Hahn Hejin   Lee Maximilian  

Digestive Diseases and Sciences, Vol. 59, Iss. 4, 2014-04 ,pp. : 737-739

Springer Publishing Company

Access to resources Recommend Favorite

Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load

By Mizuta Toshihiko   Kawaguchi Yasunori   Eguchi Yuichiro   Takahashi Hirokazu   Ario Keisuke   Akiyama Takumi   Oza Noriko   Otsuka Taiga   Kuwashiro Takuya   Yoshimura Toru   Hisatomi Akitaka   Ozaki Iwata  

Digestive Diseases and Sciences, Vol. 55, Iss. 1, 2010-01 ,pp. : 183-189

Springer Publishing Company

Access to resources Recommend Favorite

Swiss Multicenter Study Evaluating the Efficacy, Feasibility and Safety of Peginterferon-Alfa-2a and Ribavirin in Patients with Chronic Hepatitis C in Official Opiate Substitution Programs

By  

Digestion, Vol. 78, Iss. 2-3, 2008-11 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism

By  

Digestion, Vol. 68, Iss. 1, 2003-10 ,pp. : 1-4

Karger

Access to resources Recommend Favorite